I love the P data too. Looks to be better than Otzela in efficacy and safety for Moderate to Severe Psoriasis, only need more numbers to make the claim. As far as mild Psoriasis, which many negative posts have spawned on this board, is almost impossible to show efficacy, because normal remission overlaps too much with a trial period. Maybe if you had a 2 year trial period you could show discernible efficacy, Otzela couldn't. Can hardly wait to squash those "See More of You" Otzela and Humira and "See Me" commercials. Biologics...yuk.